Pharma Journalist - Page 21 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Shionogi Expands Stake in ViiV Healthcare After Pfizer Exit

AstraZeneca Secures Full Global Rights to AbelZeta’s C-CAR031

iRegene’s Parkinson’s Cell Therapy Secures FDA RMAT Designation

Novartis’ Ianalumab Earns FDA Breakthrough Status in Sjögren’s Disease

AstraZeneca Acquires Modella AI to Advance Oncology Innovation

Agenus, Zydus Finalize Strategic Immunotherapy Collaboration

EMA, FDA Set Global Principles for AI in Medicines

InterAx, Alveus Partner to Advance Next-Generation Obesity Therapy

Illumina Launches Billion Cell Atlas to Power AI Drug Discovery

Novartis Licenses SciNeuro’s Brain-Targeting Alzheimer’s Antibody Program